Vc Thoughts, Health, Dna, Rna, Healthcare.
a clinically active gene (otoferlin). It remains to be seen if Vector Biopharma will be successful with another approach, i.e. to create more capacity in a single AAV by developing larger particles based on adenovirus. The objective for all these technologies is the same: deliver larger payloads.